Sodium-glucose cotransporter 2 inhibitor therapy reduces the administration frequency of steroid injection in patients with diabetic macular edema: A cohort study using the Japanese health insurance claims database.
Ryoichi IshibashiMasaya KoshizakaYoko TakatsunaTomoaki TatsumiYoshiro MaezawaYuki ShikoYosuke InabaYohei KawasakiYusuke KashiwagiEiryo KawakamiShuichi YamamotoKoutaro YokotePublished in: Journal of diabetes investigation (2024)
The use of SGLT2is reduced the frequency of TA injection in patients with DME. Therefore, SGLT2i therapy might be a novel, noninvasive and low-cost adjunctive therapy for DME.